Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Marc LaForce

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Vaccine|June 21, 2011
Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the futureF Marc LaForce
Vaccine|April 25, 2012
Critical episodes in the understanding and control of epidemic meningococcal meningitisAndrew W Artenstein, F Marc LaForce
Vaccine|June 6, 2007
The promise of conjugate vaccines for AfricaMarie Paule Kieny, F Marc LaForce
Health Affairs (Project Hope)|June 10, 2011
Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccineF Marc LaForce, Jean-Marie Okwo-Bele
Journal of Health, Population, and Nutrition|December 22, 2004
Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration projectMontse Soriano-Gabarró, Nancy Rosenstein, F Marc LaForce
Human Vaccines & Immunotherapeutics|April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForce
Vaccine|May 30, 2009
Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solutionF Marc LaForce, Neil Ravenscroft, Mamoudou Djingarey, et al.
Human Vaccines & Immunotherapeutics|October 20, 2017
Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac<sup>R</sup>)Prasad S Kulkarni, Suresh S Jadhav, F Marc LaForce
Vaccine|May 25, 2007
The Meningitis Vaccine ProjectF Marc LaForce, Kader Konde, Simonetta Viviani, et al.
Human Vaccines & Immunotherapeutics|October 3, 2017
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next stepsF Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Vaccine|June 21, 2011
Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the futureF Marc LaForce
Vaccine|April 25, 2012
Critical episodes in the understanding and control of epidemic meningococcal meningitisAndrew W Artenstein, F Marc LaForce
Vaccine|June 6, 2007
The promise of conjugate vaccines for AfricaMarie Paule Kieny, F Marc LaForce
Health Affairs (Project Hope)|June 10, 2011
Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccineF Marc LaForce, Jean-Marie Okwo-Bele
Journal of Health, Population, and Nutrition|December 22, 2004
Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration projectMontse Soriano-Gabarró, Nancy Rosenstein, F Marc LaForce
Human Vaccines & Immunotherapeutics|April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForce
Vaccine|May 30, 2009
Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solutionF Marc LaForce, Neil Ravenscroft, Mamoudou Djingarey, et al.
Human Vaccines & Immunotherapeutics|October 20, 2017
Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac<sup>R</sup>)Prasad S Kulkarni, Suresh S Jadhav, F Marc LaForce
Vaccine|May 25, 2007
The Meningitis Vaccine ProjectF Marc LaForce, Kader Konde, Simonetta Viviani, et al.
Human Vaccines & Immunotherapeutics|October 3, 2017
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next stepsF Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Pageof 5